VALL D'HEBRON INSTITUTE OF ONCOLOGY
VHIO is a center of biomedical research with scientists and physicians working together at the nexus of basic science and clinical research.
VALL D'HEBRON INSTITUTE OF ONCOLOGY
Industry:
Biotechnology Medical
Founded:
2006-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.vhio.net
Total Employee:
51+
Status:
Active
Contact:
+34 93 254 34 50
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps
Similar Organizations
hVIVO
hVIVO is a contract virology research company that aims to develop antivirals and vaccines in the field of biomedical research.
IMMR
IMMR is a research is a contract research organization company that conducts and designs biotech and medtech preclinical surgical research.
SciLifeLab
SciLifeLab is a centre for molecular biosciences with a focus on health and environmental research.
Current Employees Featured
Official Site Inspections
http://www.vhio.net Semrush global rank: 863.05 K Semrush visits lastest month: 33.27 K
- Host name: vxadq-58.srv.cat
- IP address: 185.34.192.205
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Vall d'Hebron Institute of Oncology"
Organizational Chart - VHIO
Organized into three main programs – Preclinical & Translational, Clinical, and Core Technologies, our research focuses on understanding the fundamental biology of human cancer, from cellular and molecular biology and genetics …See details»
Institutional Organization and Administrative Structure - VHIO
To promote and develop scientific research of excellence in all aspects, especially basic, translational and clinical. Promote and develop scientific cooperation between national and …See details»
Home - VHIO
The Vall d’Hebron Institute of Oncology (VHIO) is a reference center for personalized medicine in oncology created in 2006.See details»
Vall d'Hebron Institute of Oncology (VHIO) - LinkedIn
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. CERCA Centre. Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of...See details»
Vall d'Hebron Institute of Oncology (VHIO) Information
Vall d'Hebron Institute of Oncology (VHIO) is a Research, Hospitals & Clinics, and Biotechnology company located in Barcelona, Catalonia with $14.7 million in revenue and 524 employees. …See details»
Medical Xpress - Vall d'Hebron Institute of Oncology
Vall d'Hebron Institute of Oncology (VHIO) is a center of biomedical research with scientists and physicians working together at the nexus of basic science and clinical research. Its...See details»
Vall Hebron Institut of Oncology (VHIO) | UICC
Sep 4, 2024 · Our main purpose is to promote and develop research excellence relating to oncological diseases. VHIO also pursues to make contributions to the development of new …See details»
2022 Scientific Report - VHIO
From the 2020 call, VHIO was the only newly accredited Severo Ochoa Center of Excellence in 2022, alongside the other six re-awarded research centers. Set within the Vall d’Hebron …See details»
Paolo Nuciforo MD, PhD - B·DEBATE
Jul 11, 2018 · Paolo Nuciforo MD, PhD, board certified Pathologist, Principal Investigator of the Molecular Oncology group at Vall d`Hebron Institute of Oncology (VHIO, http://www.vhio.net/en/molecular-oncology-group). He head …See details»
Corporate information - VHIO
CELLEX CENTER. C/ Natzaret, 115-117 08035 – BARCELONA – Spain Tel: +34 93 254 34 50 email: [email protected]See details»
Leadership 2023-2024 – Volunteer Health Interpreters …
I joined VHIO as a first year as I was intrigued by VHIO’s mission to bridge the language and cultural barriers between LEP populations and their access to healthcare. The idea of being able to use what I had—the ability to speak a …See details»
2022 Scientific Report - memorias.vhio.net
VHIO can and will only deliver on its goal of accelerating the pace in advancing personalized and targeted therapies against cancer thanks to the public funding it receives as well as the …See details»
2022 Scientific Report - memorias.vhio.net
VHIO (co) organized/hosted patient engagement events, fundraising and public outreach activities in 2022. VHIO continues to meet the high standards in quality and procedures in the audit of …See details»
Vall d'Hebron Institute of Oncology - ZoomInfo
Oct 23, 2023 · View Vall d'Hebron Institute of Oncology (www.vhio.net) location in Catalonia, Spain , revenue, industry and description. Find related and similar companies as well as …See details»
Volunteer Health Interpreters Organization – Healthcare without ...
Proposed in 2006 and established in 2007, we are UC Berkeley's Volunteer Health Interpreters Organization. We provide free health interpretation and translation services for low-English …See details»
2023 Scientific Report - VHIO
VHIO - CaixaResearch Scientific Seminars in 2023. Coordinated by the VHIO Academy, the VHIO – CaixaResearch Scientific Seminars Series welcomes internationally renowned researchers …See details»
Phase I prognostic online (PIPO): A web tool to improve patient ...
Methods: Using a training cohort with consecutive patients from the VHIO phase 1 unit, we constructed a prognostic model to predict median OS (mOS) as a primary endpoint and 3- …See details»
Annual Scientific Report - VHIO
VHIO’s annual Scientific Reports are compiled as follows: a ‘light’ and limited version in-print (incorporating corresponding QR codes to online version), the print version as an interactive …See details»
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in ...
Development of second-generation drugs, such as isotype-specific PI3K inhibitors, has been associated with improved outcomes in patients with non-colorectal PI3KCA-mutated cancer …See details»
Trustees - VHIO
From its inception and constitution the VHIO has had the support of private and public funding. Private initiative is a key source, either by means of competitive support or philanthropic projects.See details»